PharmaEssentia Corporation
6446
Rang în acțiuni
#1443
PharmaEssentia Corporation is a biopharmaceutical firm dedicated to developing... PharmaEssentia Corporation is a biopharmaceutical firm dedicated to developing therapies for human ailments, serving both the Taiwanese and international markets. Its product portfolio prominently features Ropeginterferon alfa-2b, indicated for the management of various hematological conditions including chronic myelogenous leukemia, T-Cell leukemia, early myelofibrosis, polycythemia vera, and essential thrombocythemia. Beyond this, the company's pipeline includes TCRT, anti PD-1, PEG-cytokine X,Y, and novel checkpoint antibodies, all under development for solid tumors. A specific combination, P1101 + anti PD-1, is being explored for hepatocellular carcinoma, while PEG-GCSF addresses neutropenia. Fundamentally, its comprehensive research and development initiatives span key therapeutic areas such as hematology, infectious diseases, and oncology. Established in 1990, PharmaEssentia Corporation maintains its headquarters in Taipei, Taiwan.
Preț acțiune
$36.73
Ultima sincronizare: 2026-10-20
Capitalizare de piață
$15.19B
Schimbare (1 zi)
-1.70%
Schimbare (1 an)
141.45%
Țară
TW
Tranzacționează PharmaEssentia Corporation (6446)
Categorie
Healthcare
Istoricul spliturilor pentru PharmaEssentia Corporation (6446)
Acțiunea PharmaEssentia Corporation (simbol: 6446) a trecut printr-un total de 2 splituri.
Cel mai recent split a avut loc pe Jul 09, 2026.
O acțiune 6446 cumpărată înainte de Sep 11, 2025 este echivalentă astăzi cu 1.229881 acțiuni 6446.
Cel mai recent split a avut loc pe Jul 09, 2026.
O acțiune 6446 cumpărată înainte de Sep 11, 2025 este echivalentă astăzi cu 1.229881 acțiuni 6446.
Listă splituri acțiuni
| An | Split | Multiplu | Multiplu cumulativ |
|---|---|---|---|
| 2026-07-09 | 1109:1000 | x1.109 | x1.229881 |
| 2025-09-11 | 1109:1000 | x1.109 | x1.109 |
Splituri pentru companii similare sau competitori
| Companie | Număr total de splituri | Multiplu cumulativ | Țara |
|---|---|---|---|
| 0 | - |
DE
|
|
| 0 | - |
DE
|
|
| 0 | - |
JP
|
|
| 0 | - |
CH
|
|
| 5 | x119 |
IN
|
